Sean Duffy Sells 14,960 Shares of Omada Health (NASDAQ:OMDA) Stock

Posted by Brian Himes on Sep 16th, 2026

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CEO Sean Duffy sold 14,960 shares of the company’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.87, for a total value of $327,175.20. Following the transaction, the chief executive officer directly owned 382,594 shares of the company’s stock, valued at approximately $8,367,330.78. This trade represents a 3.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Omada Health Stock Down 4.0%

Shares of OMDA opened at $19.67 on Wednesday. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The stock has a market capitalization of $1.20 billion, a P/E ratio of 393.40 and a beta of 1.86. The company has a 50 day moving average of $22.52 and a 200-day moving average of $18.09.

Omada Health (NASDAQ:OMDA – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. On average, sell-side analysts anticipate that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on OMDA shares. BTIG Research restated a “buy” rating and issued a $35.00 price objective on shares of Omada Health in a report on Friday, September 11th. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. BMO Capital Markets restated an “outperform” rating and issued a $24.00 price target on shares of Omada Health in a research note on Friday, August 7th. Robert W. Baird boosted their price target on Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 12th. Finally, Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Eleven analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Omada Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $26.67.

View Our Latest Stock Analysis on Omada Health

Hedge Funds Weigh In On Omada Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Integrated Wealth Concepts LLC bought a new position in shares of Omada Health in the second quarter valued at about $53,000. Versant Capital Management Inc boosted its holdings in shares of Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after buying an additional 2,283 shares during the period. Legal & General Group Plc acquired a new position in Omada Health in the 2nd quarter valued at about $76,000. Fifth Third Bancorp acquired a new position in Omada Health in the 1st quarter valued at about $127,000. Finally, Entropy Technologies LP bought a new position in Omada Health in the 1st quarter valued at about $194,000.

About Omada Health

(Get Free Report)

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.